Therapeutic applications of sugar-mimicking glycosidase inhibitors

Mini Rev Med Chem. 2001 Jul;1(2):145-54. doi: 10.2174/1389557013407052.

Abstract

Sugar-mimicking alkaloids inhibit the glycosidases involved in a wide range of important biological processes, principally owing to their structural resemblance to the sugar moiety of the natural substrate. The possibility of modifying and blocking these processes by using such inhibitors for therapeutic applications has attracted a lot of attention.

Publication types

  • Review

MeSH terms

  • 1-Deoxynojirimycin / analogs & derivatives
  • Animals
  • Carbohydrate Sequence
  • Disaccharides / chemical synthesis*
  • Disaccharides / therapeutic use*
  • Drug Design
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / therapeutic use*
  • Glucosamine / analogs & derivatives*
  • Glucosamine / chemical synthesis
  • Glucosamine / chemistry
  • Glucosamine / pharmacology
  • Glycoside Hydrolases / antagonists & inhibitors*
  • Humans
  • Mannosidases / antagonists & inhibitors
  • Models, Molecular
  • Molecular Sequence Data
  • Oligosaccharides / chemical synthesis
  • Oligosaccharides / therapeutic use
  • Structure-Activity Relationship
  • alpha-Galactosidase / antagonists & inhibitors
  • alpha-Mannosidase

Substances

  • Disaccharides
  • Enzyme Inhibitors
  • Oligosaccharides
  • 1-Deoxynojirimycin
  • Glycoside Hydrolases
  • Mannosidases
  • alpha-Galactosidase
  • alpha-Mannosidase
  • Glucosamine
  • nojirimycin